Guru Teg Bahadur Hospital (or GTBH or GTB Hospital) is a large hospital situated at Dilshad Garden, Shahdara, Delhi, India, and is affiliated to and acts as the teaching hospital of University College of Medical Sciences, University of Delhi. GTBH was established in 1979[citation needed] (fully functional in 1987) with a 350-bed capacity which has been expanded to 1700-beds. It is the first Delhi Government tertiary care hospital in the Trans-Yamuna area, catering to the East Delhi population as well as people from adjacent states.
Sarcopenia is a progressive loss of muscle mass. This study aims to determine the association of pre-operative sarcopenia with the outcome of cervical spine surgery. Pubmed, Ovid, Embase, and Web of Sciences databases were searched until September 2023 to include articles regarding the prognostic role of preoperative sarcopenia in cervical spine surgery patients. The Quality In Prognosis Studies (QUIPS) tool was used to assess the risk of bias. Meta-analyses Of Observational Studies in Epidemiology (MOOSE) and Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines were followed. The vote-counting model was used for the qualitative appraisal of the studies. Statistical analysis was performed with a significant p < 0.05 using SPSS software (version 23). Of the 1,134 articles revealed from the search, 15 studies with 1463 patients were included. A significant difference between patients with and without sarcopenia was not found for the occurrence of loss of lordosis (OR = 1.28, 95
To compare the diagnostic utility of the H-Score and modified HLH-2004 criteria in patients with suspected secondary HLH. A retrospective review of 10 secondary HLH patients diagnosed between August 2022 and July 2023 was conducted. Clinical, laboratory, and bone marrow findings were analyzed. Patients were classified by both modified HLH-2004 criteria (modified due to limited availability of NK cell function and sCD25) and the H-Score. Fever and hyperferritinemia were present in all patients. Cytopenias, hepatosplenomegaly, and marrow hemophagocytosis were frequent. Infections, particularly tuberculosis, hematological malignancies, and metabolic disorders were some of the triggers. Concordance between HLH-2004 criteria and H- Score was 70
Revision surgery for OPLL is undesirable for both patients and physicians. However, the risk factors for reoperation are not clear. Thus, we sought to review the existing literature and determine the factors associated with higher reoperation rates in patients with OPLL. A search was performed using Pubmed, Embase, Web of Sciences, and Ovid to include studies regarding the risk factors of reoperation for OPLL. RoBANS (Risk of Bias Assessment tool for Nonrandomized Studies) was used for risk of bias analysis. Heterogeneity of studies and publication bias was assessed, and sensitivity analysis was performed. Statistical analysis was performed with a p-value < 0.05 using SPSS software (version 23). Twenty studies with 129 reoperated and 2,793 non-reoperated patients were included. The pooled reoperation rate was 5
Acquired palatal defects may arise from trauma, infection, pathology, radiation therapy, or surgical resection, resulting in oro-nasal communication that adversely affects speech, swallowing, mastication, and patient morale. Obturator prostheses are commonly used to restore these functions; however, in extensive maxillectomy defects, increased prosthesis weight and the absence of adequate retentive undercuts may compromise retention, stability, and patient comfort. Hollowing of the obturator is an effective method for reducing prosthesis weight and improving function. This clinical report describes the rehabilitation of a patient with a total maxillectomy defect secondary to COVID-19-associated mucormycosis using a simplified reverse hollowing technique for fabrication of a definitive obturator. Reverse hollowing was performed from the palatal aspect following conventional processing, and an acrylic shim was incorporated to re-establish palatal contour, thereby improving speech resonance and swallowing efficiency. A heat-cured resilient liner (Molloplast B) was used to engage soft-tissue undercuts and enhance retention. The described technique is simple, efficient, economical, and reproducible, and may be particularly useful in extensive defects where conventional hollowing procedures are difficult to perform.
Abstract Background and Aims: Ambu ® AuraGain™ (AAG) can act as an intubation conduit by controlling soft-tissue collapse and helping in direct visualisation of the glottis with the fibre-optic scope. One previous study has evaluated the use of AAG as a conduit for blind intubation as well as for fibre-optic-guided tracheal intubation in manikin only. Hence, this study was designed with the aim to evaluate AAG for tracheal intubation with or without the use of fibre-optic guidance in patients undergoing surgery in general anaesthesia, with the hypothesis that fibre-optic intubation through AAG will take lesser time as it will be done under direct visualisation. Materials and Methods: It was randomised controlled study. Patients with American Society of Anesthesiologists physical status II/III, patients of either gender, age 18–60 years and mouth opening of 3 finger breadths were included. The primary objective was to evaluate the time taken for successful tracheal intubation with or without fibre-optic guidance through AAG. The Mann–Whitney U -test and Pearson Chi-square/Fisher’s test were used for statistical analysis. Results: The mean time for successful tracheal intubation with fibre-optic guidance was 105.5 ± 31.85 s and without fibre-optic guidance was 19.75 ± 5.36 s, which was statistically significant, P < 0.001. Conclusion: Our study concludes that AAG can be used as a conduit for both fibre-optic-guided and non-guided endotracheal intubation.
